Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ASTC logo ASTC
Upturn stock ratingUpturn stock rating
ASTC logo

Astrotech Corp (ASTC)

Upturn stock ratingUpturn stock rating
$5.78
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: ASTC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$5.78
high$

Analysis of Past Performance

Type Stock
Historic Profit -19.92%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 9.64M USD
Price to earnings Ratio -
1Y Target Price 25
Price to earnings Ratio -
1Y Target Price 25
Volume (30-day avg) -
Beta 0.24
52 Weeks Range 5.39 - 12.29
Updated Date 06/29/2025
52 Weeks Range 5.39 - 12.29
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -8.35

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -724.16%

Management Effectiveness

Return on Assets (TTM) -27.99%
Return on Equity (TTM) -44.54%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -11109408
Price to Sales(TTM) 10.67
Enterprise Value -11109408
Price to Sales(TTM) 10.67
Enterprise Value to Revenue 49.38
Enterprise Value to EBITDA 1.79
Shares Outstanding 1693950
Shares Floating 1158844
Shares Outstanding 1693950
Shares Floating 1158844
Percent Insiders 16.91
Percent Institutions 22.89

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Astrotech Corp

stock logo

Company Overview

overview logo History and Background

Astrotech Corp. was founded in 1984 and has evolved from a space technology company to one focusing on commercializing technology derived from space research. It has faced financial difficulties and restructured operations over the years.

business area logo Core Business Areas

  • Astrotech Technologies: Focuses on commercializing advanced technology including mass spectrometry devices for various applications.

leadership logo Leadership and Structure

Astrotech's leadership consists of its CEO and a board of directors. The organizational structure is streamlined, reflecting its smaller size and focus.

Top Products and Market Share

overview logo Key Offerings

  • AgLAB: A mass spectrometer for agricultural applications, designed to rapidly detect pathogens and other contaminants in food and water. Market share data unavailable. Competitors include Thermo Fisher Scientific (TMO) and Agilent Technologies (A).
  • BreathTech: A potential breath analysis device for medical diagnostics. Early stage of development, no market share data available. Competitors include Owlstone Medical (Private) and Metabolon (Private).

Market Dynamics

industry overview logo Industry Overview

Astrotech operates in the analytical instrumentation market, specifically mass spectrometry and related fields. This market is driven by increasing demand for advanced testing and analysis in various sectors.

Positioning

Astrotech is a niche player focusing on specific applications for its core technology. Its competitive advantage lies in its proprietary technology and potential for unique solutions. The risk is that the company is thinly capitalized and relies heavily on grants, and strategic capital.

Total Addressable Market (TAM)

The TAM for mass spectrometry and related analytical instrumentation is estimated to be several billion dollars. Astrotech is targeting specific segments within this market, with the goal to secure a small percentage of the TAM, making it worth potentially hundreds of millions of dollars.

Upturn SWOT Analysis

Strengths

  • Proprietary technology in mass spectrometry
  • Potential for unique solutions in niche markets
  • Experienced management team

Weaknesses

  • Limited financial resources
  • Dependence on grants and contracts
  • Small market capitalization
  • History of losses
  • Volatility in stock price

Opportunities

  • Growing demand for advanced analytical instrumentation
  • Potential partnerships with larger companies
  • Expansion into new markets
  • Securing additional government grants

Threats

  • Competition from larger, well-established companies
  • Technological obsolescence
  • Economic downturns
  • Regulatory changes

Competitors and Market Share

competitor logo Key Competitors

  • TMO
  • ABT
  • ILMN

Competitive Landscape

Astrotech faces significant competition from larger, well-funded companies in the analytical instrumentation market. Its ability to compete depends on its proprietary technology and niche market focus.

Growth Trajectory and Initiatives

Historical Growth: Astrotech's historical growth has been limited and inconsistent, due to financial challenges and market conditions.

Future Projections: Future growth projections are uncertain and dependent on the company's ability to commercialize its technology and secure funding.

Recent Initiatives: Recent initiatives include focusing on agricultural and medical applications for its mass spectrometry technology and pursuing strategic partnerships.

Summary

Astrotech Corp is a small company with promising technology facing considerable financial hurdles. Its ability to secure funding and successfully commercialize its technology will determine its future. The company needs to focus on strategic partnerships and market expansion to survive and thrive. Investors should watch out for further dilution of stock and cash burn rate.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Market research reports
  • Analyst estimates

Disclaimers:

This analysis is based on publicly available information and is not financial advice. Investment decisions should be made based on individual circumstances and consultation with a qualified financial advisor.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Astrotech Corp

Exchange NASDAQ
Headquaters Austin, TX, United States
IPO Launch date 1995-12-20
CEO, CTO & Chairman Mr. Thomas Boone Pickens III
Sector Technology
Industry Scientific & Technical Instruments
Full time employees 30
Full time employees 30

Astrotech Corporation operates as a mass spectrometry company worldwide. It owns and licenses the intellectual property related to the Astrotech Mass Spectrometer Technology, a platform mass spectrometry technology. The company also develops TRACER 1000, a mass spectrometer-based explosive trace detector to replace the explosives trace detectors used at airports, cargo and other secured facilities, and borders. In addition, it develops AGLAB-1000, a mass spectrometer for use in the hemp and cannabis market. Further, the company develops BreathTest-1000, a breath analysis tool to screen for volatile organic compound metabolites found in a person's breath; and Pro-Control 1000-D2, a mass spectrometer. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.